Most clinical practice guidelines for rosacea identify the primary objective as clearing the visible signs of rosacea, while unseen symptoms such as burning and stinging are not always addressed even though they add to patients’ burden of disease and lower quality of life, according to a review of studies on burning and/or stinging in individuals with rosacea recently published in the European journal Acta Dermato-Venereologica.1
A majority of rosacea patients have experienced eye irritation since being diagnosed with rosacea, but most have not been treated for the eye symptoms of ocular rosacea.
While the ravages of subtype 3 (phymatous) rosacea have been well documented throughout history, today a multitude of options are available to restore a red, swollen or bumpy nose (rhinophyma) to normal appearance.
Although subtype 3 (phymatous) rosacea often involves excess tissue, it can be effectively treated with a range of options appropriate for the severity of the case, according to the standard management options for rosacea recently published by the National Rosacea Society.1
Soothing cleansing and other measures in addition to medical therapy may help relieve the symptoms of subtype 4 (ocular) rosacea, according to the standard management options for rosacea recently published by the National Rosacea Society (NRS).
"Gentle care in keeping eyelids clean is especially important in keeping eyes with ocular rosacea healthy," said Dr. Marian Macsai, professor of ophthalmology at the University of Chicago and a member of the consensus committee and review panel of 26 medical experts who developed the new standard options.1
Because the flushing and facial redness of subtype 1 (erythematotelangiectatic) rosacea are difficult to treat with medical therapy, other measures may be especially important for successfully controlling this widespread form of rosacea, according to the standard management options for rosacea recently published by the National Rosacea Society (NRS).1
While some signs and symptoms of rosacea can be challenging to control, effective medical therapies have been extensively studied and approved for the treatment of the bumps and pimples of subtype 2 (papulopustular) rosacea, according to the standard management options for rosacea recently published by the National Rosacea Society.1
If potential complications and side effects of oral antibiotic therapy were minimized, the vast majority of rosacea sufferers would be more likely to accept oral therapy to treat their condition, according to results of a recent National Rosacea Society survey of 520 rosacea patients.
The National Rosacea Society (NRS) has published new standard patient care options for rosacea, developed by a consensus committee and review panel of 26 rosacea experts, and articles on the various options for controlling the many potential aspects of this widespread disorder will appear in the coming issues of Rosacea Review.1